Corporate Profile

Syndax Pharmaceuticals is a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies. Highlights of the Company's pipeline include revumenib, a highly selective inhibitor of the menin–KMT2A binding interaction, and axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1 (CSF-1) receptor. Through its pipeline agents, the Company is determined to realize a future in which people with cancer live longer and better than ever before. Syndax corporate headquarters are in Waltham, MA.

View Stock
Day High
Day Low
Volume

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Press Releases

04.10.24
Syndax Announces Participation at the Stifel 2024 Virtual Targeted Oncology Forum
WALTHAM, Mass. , April 10, 2024 /PRNewswire/ -- Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that Michael A. Metzger , Chief Executive Officer of Syndax, will participate in a fireside chat
Read More
04.08.24
Syndax Presents Positive Pediatric Data from Pivotal AUGMENT-101 Trial of Revumenib in Relapsed/Refractory KMT2Ar Acute Leukemia at ASPHO Plenary Session
– Consistent safety and efficacy profiles across adult and pediatric populations – – Majority of pediatric patients who achieved an overall response proceeded to transplant; patients receiving post-transplant revumenib maintenance remained in remission as of data cutoff date – – No
Read More
03.28.24
Syndax Announces Completion of Enrollment in AUGMENT-101 Pivotal Trial Cohort of Patients with Relapsed/Refractory mNPM1 Acute Myeloid Leukemia
–   Topline data expected in 4Q24 could support sNDA filing in 1H25 – – Revumenib has the potential to address $2 billion   mNPM1 and KMT2Ar R/R acute leukemia U.S. market opportunity – WALTHAM, Mass. , March 28, 2024 /PRNewswire/ -- Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical stage
Read More
View More
View More

Two people smiling

Recent Events

Stifel 2024 Virtual Targeted Oncology Forum

04.17.24 / 11:00 AM EDT
Learn More

Barclays Global Healthcare Conference

03.12.24 / 8:30 AM EDT
Learn More

44th Annual TD Cowen Health Care Conference (Leukemia Panel Discussion)

03.04.24 / 12:50 PM EST
Learn More
View More

Sign Up for Email Alerts

Sign-up to automatically receive Syndax financial information by email.
Sign up
Two people holding hands